- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- NAG- GAL: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 16 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.4: 7 residues within 4Å:- Chain A: P.214, R.254, N.264, R.438, C.439, E.440, S.441
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.438, A:E.440
NAG-NAG-BMA.6: 6 residues within 4Å:- Chain A: S.145, S.146, N.385, S.387
- Ligands: NAG-NAG.5, NAG-NAG.5
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.146
NAG-NAG-BMA.9: 1 residues within 4Å:- Chain C: N.137
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.11: 7 residues within 4Å:- Chain C: S.131, I.134, T.135, N.136, N.155, Y.172, D.322
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:T.135
- Hydrogen bonds: C:Y.172
NAG-NAG-BMA.14: 5 residues within 4Å:- Chain C: N.362, S.363, G.365, F.390
- Ligands: NAG.61
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.16: 1 residues within 4Å:- Chain E: N.137
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.17: 3 residues within 4Å:- Chain E: N.144, S.145
- Ligands: NAG-NAG-BMA.27
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.21: 5 residues within 4Å:- Chain E: N.236, I.274, R.275, S.276, E.352
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.22: 8 residues within 4Å:- Chain E: E.213, R.254, N.264, N.376, C.377, E.440, S.441
- Ligands: NAG.73
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:E.213
NAG-NAG-BMA.23: 5 residues within 4Å:- Chain E: T.295, N.297, N.333, E.440
- Ligands: NAG-NAG-BMA.24
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.24: 6 residues within 4Å:- Chain E: I.142, H.331, C.332, N.333, T.409
- Ligands: NAG-NAG-BMA.23
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.25: 4 residues within 4Å:- Chain E: N.355, T.356
- Ligands: NAG-NAG-BMA.28, NAG-NAG-BMA.28
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.27: 8 residues within 4Å:- Chain E: S.146, N.385, S.387, F.390, R.413
- Ligands: NAG-NAG-BMA.17, NAG-NAG.26, NAG-NAG.26
3 PLIP interactions:3 interactions with chain E- Hydrogen bonds: E:S.146, E:S.146, E:N.391
NAG-NAG-BMA.28: 4 residues within 4Å:- Chain E: H.396, N.397
- Ligands: NAG-NAG-BMA.25, NAG-NAG-BMA.25
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.29: 3 residues within 4Å:- Chain E: K.403, P.404, N.405
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.32: 3 residues within 4Å:- Chain H: T.24, N.42, T.91
No protein-ligand interaction detected (PLIP)- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.5: 5 residues within 4Å:- Chain A: N.362, S.363, T.371
- Ligands: NAG-NAG-BMA.6, NAG-NAG-BMA.6
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 1 residues within 4Å:- Chain B: N.101
No protein-ligand interaction detected (PLIP)NAG-NAG.8: 4 residues within 4Å:- Chain B: E.124, S.126, N.127, Y.128
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 3 residues within 4Å:- Chain C: N.144, S.146, N.148
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 12 residues within 4Å:- Chain C: P.214, R.254, V.256, L.263, N.264, N.376, C.377, G.378, R.438, C.439, E.440
- Ligands: NAG.64
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:G.378, C:E.440, C:E.440
NAG-NAG.15: 1 residues within 4Å:- Chain E: N.133
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 8 residues within 4Å:- Chain E: D.129, I.134, T.135, N.155, C.156, S.157, Y.172, D.322
1 PLIP interactions:1 interactions with chain E- Hydrophobic interactions: E:T.135
NAG-NAG.20: 3 residues within 4Å:- Chain E: R.194, N.199, T.200
No protein-ligand interaction detected (PLIP)NAG-NAG.26: 6 residues within 4Å:- Chain E: N.362, S.363, T.371, S.387
- Ligands: NAG-NAG-BMA.27, NAG-NAG-BMA.27
No protein-ligand interaction detected (PLIP)NAG-NAG.30: 2 residues within 4Å:- Chain F: S.126, N.127
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.19: 16 residues within 4Å:- Chain E: T.127, L.128, D.129, S.157, N.159
- Chain G: E.21, R.117, W.124, H.125, D.127, D.144
- Chain H: D.71, H.74, R.75, S.77, G.78
5 PLIP interactions:2 interactions with chain H, 3 interactions with chain G- Hydrogen bonds: H:S.77, H:G.78, G:R.117, G:D.144, G:D.144
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 44 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.33: 4 residues within 4Å:- Chain A: N.87
- Chain B: A.16, G.17, S.18
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain A: N.137, I.138, D.326, R.328
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain A: T.143, N.144
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain A: N.187
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain A: N.236
Ligand excluded by PLIPNAG.38: 6 residues within 4Å:- Chain A: Y.84, E.86, N.231, D.232, K.242, N.243
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain A: N.278
Ligand excluded by PLIPNAG.40: 6 residues within 4Å:- Chain A: G.270, V.272, N.291, E.292, Q.345, Q.349
Ligand excluded by PLIPNAG.41: 5 residues within 4Å:- Chain A: T.295, I.296, N.297, E.440
- Ligands: NAG.43
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain A: N.303, I.324, V.436
Ligand excluded by PLIPNAG.43: 5 residues within 4Å:- Chain A: N.297, H.331, N.333, R.438
- Ligands: NAG.41
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain A: N.355, T.356, H.396
- Ligands: NAG.46
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain A: N.393, T.395, H.396
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain A: T.356, H.396, N.397
- Ligands: NAG.44
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain A: K.403, N.405
Ligand excluded by PLIPNAG.48: 1 residues within 4Å:- Chain A: N.442
Ligand excluded by PLIPNAG.49: 3 residues within 4Å:- Chain A: W.354, N.457, E.458
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain B: K.107, E.111, N.115
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: E.86, N.87
- Chain D: S.18
Ligand excluded by PLIPNAG.52: 5 residues within 4Å:- Chain C: S.131, Y.132, N.133, I.134, T.135
Ligand excluded by PLIPNAG.53: 4 residues within 4Å:- Chain C: R.194, N.199, T.200
- Chain E: R.310
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.236
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain C: N.278, T.280
Ligand excluded by PLIPNAG.56: 5 residues within 4Å:- Chain C: G.270, K.271, V.272, N.291, Q.345
Ligand excluded by PLIPNAG.57: 5 residues within 4Å:- Chain C: T.295, I.296, N.297, C.439, E.440
Ligand excluded by PLIPNAG.58: 4 residues within 4Å:- Chain C: N.303, N.304, T.305, I.324
Ligand excluded by PLIPNAG.59: 4 residues within 4Å:- Chain C: N.297, H.331, N.333, R.438
Ligand excluded by PLIPNAG.60: 1 residues within 4Å:- Chain C: N.355
Ligand excluded by PLIPNAG.61: 5 residues within 4Å:- Chain C: V.147, N.385, S.387
- Ligands: NAG-NAG-BMA.14, NAG-NAG-BMA.14
Ligand excluded by PLIPNAG.62: 3 residues within 4Å:- Chain C: I.359, N.393, T.395
Ligand excluded by PLIPNAG.63: 3 residues within 4Å:- Chain C: M.402, K.403, N.405
Ligand excluded by PLIPNAG.64: 5 residues within 4Å:- Chain C: R.254, N.264, T.293, N.442
- Ligands: NAG-NAG.13
Ligand excluded by PLIPNAG.65: 2 residues within 4Å:- Chain D: N.101, S.103
Ligand excluded by PLIPNAG.66: 4 residues within 4Å:- Chain E: E.86, N.87
- Chain F: G.17, S.18
Ligand excluded by PLIPNAG.67: 3 residues within 4Å:- Chain E: N.187
- Chain G: G.45, F.46
Ligand excluded by PLIPNAG.68: 6 residues within 4Å:- Chain E: Y.84, N.231, D.232, K.233, K.242, N.243
Ligand excluded by PLIPNAG.69: 2 residues within 4Å:- Chain E: N.278, N.281
Ligand excluded by PLIPNAG.70: 4 residues within 4Å:- Chain E: K.271, V.272, N.291, Q.345
Ligand excluded by PLIPNAG.71: 3 residues within 4Å:- Chain E: N.303, N.304, Q.434
Ligand excluded by PLIPNAG.72: 4 residues within 4Å:- Chain E: F.390, N.391, S.392, N.393
Ligand excluded by PLIPNAG.73: 5 residues within 4Å:- Chain E: R.254, N.264, T.293, N.442
- Ligands: NAG-NAG-BMA.22
Ligand excluded by PLIPNAG.74: 2 residues within 4Å:- Chain E: N.457, E.458
Ligand excluded by PLIPNAG.75: 3 residues within 4Å:- Chain F: N.101, S.102, S.103
Ligand excluded by PLIPNAG.76: 3 residues within 4Å:- Chain F: E.111, E.114, N.115
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pan, J. et al., Cryo-EM Structure of Full-length HIV-1 Env Bound With the Fab of Antibody PG16. J.Mol.Biol. (2020)
- Release Date
- 2020-04-29
- Peptides
- envelope glycoprotein gp120,envelope glycoprotein gp120: ACE
Envelope glycoprotein gp41: BDF
antibody PG16 Fab heavy chain: G
antibody PG16 Fab light chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
HH
L
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- NAG- GAL: beta-D-galactopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-2)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 16 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 1 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 44 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Pan, J. et al., Cryo-EM Structure of Full-length HIV-1 Env Bound With the Fab of Antibody PG16. J.Mol.Biol. (2020)
- Release Date
- 2020-04-29
- Peptides
- envelope glycoprotein gp120,envelope glycoprotein gp120: ACE
Envelope glycoprotein gp41: BDF
antibody PG16 Fab heavy chain: G
antibody PG16 Fab light chain: H - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
HH
L